Bergenbio ASA (Norway) Executives
| BGBIO Stock | NOK 1.67 0.04 2.34% |
Bergenbio ASA employs about 34 people. The company is managed by 9 executives with a total tenure of roughly 7 years, averaging almost 0.0 years of service per executive, having 3.78 employees per reported executive. Analysis of Bergenbio ASA's management performance can provide insight into the firm performance.
| Rune Skeie Executive Chief Officer |
| Debbie Molyneux Insider Chief Officer |
Bergenbio |
Bergenbio ASA Management Team Effectiveness
The company has return on total asset (ROA) of (0.4939) % which means that it has lost $0.4939 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.9551) %, meaning that it generated substantial loss on money invested by shareholders. Bergenbio ASA's management efficiency ratios could be used to measure how well Bergenbio ASA manages its routine affairs as well as how well it operates its assets and liabilities.Bergenbio ASA Workforce Comparison
Bergenbio ASA is number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 248. Bergenbio ASA retains roughly 34.0 in number of employees claiming about 14% of equities under Health Care industry.
Bergenbio ASA Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Bergenbio ASA Price Series Summation is a cross summation of Bergenbio ASA price series and its benchmark/peer.
Bergenbio ASA Notable Stakeholders
A Bergenbio ASA stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Bergenbio ASA often face trade-offs trying to please all of them. Bergenbio ASA's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Bergenbio ASA's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Rune Skeie | Chief Officer | Profile | |
| Debbie Molyneux | Chief Officer | Profile | |
| Nigel MSc | Chief Officer | Profile | |
| Alison Messom | Director Operations | Profile | |
| James Barnes | Chief Officer | Profile | |
| Cristina MD | Chief Officer | Profile | |
| Martin Olin | Chief Officer | Profile | |
| Gayle MBA | Chief Officer | Profile | |
| Akil Jackson | Medical Director | Profile |
About Bergenbio ASA Management Performance
The success or failure of an entity such as Bergenbio ASA often depends on how effective the management is. Bergenbio ASA management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Bergenbio management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Bergenbio management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
BerGenBio ASA, a clinical-stage biopharmaceutical company, develops medicines to treat immune evasive, drug resistant, and metastatic cancers. The company was founded in 2007 and is headquartered in Bergen, Norway. BerGenBio ASA is traded on Oslo Stock Exchange in Norway.
Bergenbio ASA Workforce Analysis
Traditionally, organizations such as Bergenbio ASA use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Bergenbio ASA within its industry.Bergenbio ASA Manpower Efficiency
Return on Bergenbio ASA Manpower
| Revenue Per Employee | 22.8K | |
| Revenue Per Executive | 86K | |
| Net Loss Per Employee | 9.1M | |
| Net Loss Per Executive | 34.4M |
Other Information on Investing in Bergenbio Stock
Bergenbio ASA financial ratios help investors to determine whether Bergenbio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bergenbio with respect to the benefits of owning Bergenbio ASA security.